| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58209a99602b20c360e8d2eb8b6bee97 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b42c46949e59863147ca1921f3bd18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f46b8d35d06cc66991eb59e519eae6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0158117c92b0f9f8f5e87cdeb2afaa2 |
| publicationDate |
2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016068535-A1 |
| titleOfInvention |
Pyrrolotriazines as alk inhibitors |
| abstract |
This application provides compounds of the general formula (I) n n n n n n n n n n and/or a salt thereof, where X, R 1 and R 2 are as defined herein. Compositions and therapeutic uses are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023101387-A1 |
| priorityDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |